Back

Navigating the future of transthyretin cardiac amyloidosis management: unveiling the potential of digital biomarkers for real-world cardiac progression monitoring

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in e-cardiology/digital health 6 Remote Patient Monitoring and Telehealth HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Olivier Lairez

University of Toulouse, Toulouse (France)

1 More presentation in this session

Presentation thumbnail
Non-invasive structured remote telemonitoring in advanced heart failure: a single-centre experience
Doctor M. Lima (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in e-cardiology/digital health 6

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Clinical implications of cardiac implantable electronic devices in ATTR cardiomyopathy
thumbnail
Congress Presentation
Synthetic extracellular volume from myocardial radiomics to identify transthyretin cardiac amyloidosis from routinely acquired CT angiography scans
thumbnail
Congress Presentation
Evolution over time of cardiac biomarkers, electrocardiographic and echocardiographic features in a large cohort of patients with wild-type transthyretin cardiac amyloidosis treated with tafamidis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources